To my entire Core Family ..... I personnaly fired

To my entire Core Family >..... I personnaly fired off this letter to Mr. Alan Brochstein at Seeking Alpha in which i have had previous contact and investor relations with to draw in his huge investor - financial following and very very possible write up bio to all of Seeking Alpha!!!......for your consideration: > ...        Mr.Alan Brochstein.....ticker symbol -  SCRC ......ScripsAmerica..I am and always have been an avid follower of your editorial postings and value all of your opinions for quite some time.I would like to share something very very special with you and submit ScripsAmerica for your consideration or follow up editorial article in presenting SCRC to your investor following here on Seeking Alpha which is indeed admired by so many in the investment community......Based on this mornings huge Press Release solidifies a first wholesale pharmeceutical based US company to gain REGISTRATION & REGULATORY APPROVAL to distribute RapiMeds technology in Children's aspirin form in the country of China.....The worlds biggest population and ths futuristic RapiMelt aspirin that disolves almost instataneously in one's mouth "Without' water should speak volumes along with the outcry to all that you are indeed witnessing a mini Pfizer,Merck,Glaxo etc.in the making......ScripsAmerica's RapiMelt technology opens the door now in China to offer endless possiblities to additional medicines or vitamines!!!....  February 10, 2014 - 8:30 AM EST            
ScripsAmerica's RapiMed Product Receives Registration Approval From the Hong Kong Government
Company's RapiMed(R) Children's Pain Reliever and Fever Reducer Can Now be Sold and Distributed Throughout Hong Kong
TYSONS CORNER, Va., Feb. 10, 2014 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has received registration approval for its RapiMed® Children's Pain Reliever & Fever Reducer from the Government of Hong Kong.

With the registration process complete, ScripsAmerica is now free to distribute RapiMed® throughout Hong Kong and the Company is ready to accept orders from affiliate hospital networks, and representatives of a major health product retailer with over 2,000 stores and over 500 pharmacies. Because RapiMed® is an over-the-counter (OTC) medication, it does not require FDA approval in order to be sold in Hong Kong due to the fact that its manufacturer is CGMP (Current Good Manufacturing Practices) certified.

With this certification, RapiMed®'s manufacturer needs only to follow the monograph process for the product's active ingredient. A monograph defines the safety, effectiveness, and labeling of all marketing OTC active ingredients and once a final monograph is completed, companies can make and market an OTC product without the need for FDA pre-approval.

Bob Schneiderman, CEO of ScripsAmerica, states "ScripsAmerica is very excited to announce RapiMed's registration approval by the Government of Hong Kong to allow the distribution of our children's pain reliever. Now the company can focus all of its efforts on finalizing distribution agreements with a large affiliate hospital network and major health product retailer to sell our product throughout Greater Asia."

"We believe that our product's unique and innovative rapid melt technology will lead to tremendous success in the Chinese OTC pharmaceutical market which will lead to expansion into other international markets, including new OTC drugs using our proprietary RapiMed formulation. This is a major milestone for ScripsAmerica that we believe is the beginning of significant revenue growth and increased shareholder value," Schneiderman continued.

About ScripsAmerica, Inc.

ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com .
 
ScripsAmerica [CEO] - Mr.Bob Schneiderman can be contacted at : 215-741-7006  for futher information........Thank You!.......tryz